Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Biomarkers of Leukemia Risk: Benzene as a Model

Martyn T. Smith and Luoping Zhang
Environmental Health Perspectives
Vol. 106, Supplement 4: Integrated Approaches for Studying Hazardous Substances (Aug., 1998), pp. 937-946
DOI: 10.2307/3434135
Stable URL: http://www.jstor.org/stable/3434135
Page Count: 10
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Biomarkers of Leukemia Risk: Benzene as a Model
Preview not available

Abstract

Although relatively rare, leukemias place a considerable financial burden on society and cause psychologic trauma to many families. Leukemia is the most common cancer in children. The causes of leukemia in adults and children are largely unknown, but occupational and environmental factors are strongly suspected. Genetic predisposition may also play a major role. Our aim is to use molecular epidemiology and toxicology to find the causes of leukemia and develop biomarkers of leukemia risk. We have studied benzene as a model chemical leukemogen, and we have identified risk factors for susceptibility to benzene toxicity. Numerous studies have associated exposure to benzene with increased levels of chromosome aberrations in circulating lymphocytes of exposed workers. Increased levels of chromosome aberrations have, in turn, been correlated with a heightened risk of cancer, especially for hematologic malignancy, in two recent cohort studies in Europe. Conventional chromosome analysis is laborious, however, and requires highly trained personnel. Further, it lacks statistical power, as only a small number of cells can be examined. The recently developed fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR)-based technologies have allowed the detection of specific chromosome aberrations. These techniques are far less time consuming and are more sensitive than classical chromosomal analysis. Because leukemias commonly show a variety of specific chromosome aberrations, detection of these aberrations by FISH and PCR in peripheral blood may provide improved biomarkers of leukemia risk.

Page Thumbnails

  • Thumbnail: Page 
937
    937
  • Thumbnail: Page 
938
    938
  • Thumbnail: Page 
939
    939
  • Thumbnail: Page 
940
    940
  • Thumbnail: Page 
941
    941
  • Thumbnail: Page 
942
    942
  • Thumbnail: Page 
943
    943
  • Thumbnail: Page 
944
    944
  • Thumbnail: Page 
945
    945
  • Thumbnail: Page 
946
    946